MISSISSAUGA, Ontario and BRESCIA, Italy, Dec. 21, 2020 (Globe NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix &circledR ), a daily life sciences innovator and exporter, and Copan Italia S.p.A. (Copan &circledR ), the world-wide chief in specimen selection systems, announce their execution of a strategic settlement (Settlement) in relation to Microbix&CloseCurlyQuotes quality assessment merchandise (QAPs™) and Copan&CloseCurlyQuotes flocked devices (FLOQ &circledR ).
The Arrangement amongst Microbix and Copan expands upon an present buy and supply contract, including licensing of Copan&CloseCurlyQuotes issued patents for use of flocked products to format test controls (broadly recognized as QAPs). Also, it formalizes the parties&CloseCurlyQuote agreement for joint use of their respective models for internet marketing of novel and revolutionary QAPs – Combining Copan&CloseCurlyQuotes perfectly-regarded FLOQ &circledR model with Microbix&CloseCurlyQuotes emerging PROCEEDx™ (RUO) and REDx™ (IVD) brand names – to use PROCEEDx™ FLOQ &circledR and REDx™ FLOQ&circledR as around the world branding